EP2984097
HIGHLY ACTIVE NUCLEOSIDE DERIVATIVE FOR THE TREATMENT OF HCV
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.4.2014EP published:
29.3.2017EP application number:
14722955.3
EPO information:
European Patent Register
Max expiry date:
13.4.2034
Title:
HIGHLY ACTIVE NUCLEOSIDE DERIVATIVE FOR THE TREATMENT OF HCV
Timeline
Today
14.4.2014EP application
29.3.2017EP Publication
Owner
Name:
Achillion Pharmaceuticals, Inc.Address:
300 George Street, 06511, New Haven, CT, US
Inventor
Name:
DESHPANDE, MilindAddress:
Madison, Connecticut, US
Name:
WILES, Jason AllanAddress:
Madison, Connecticut, US
Name:
HASHIMOTO, AkihiroAddress:
Branford, Connecticut, US
Name:
PHADKE, AvinashAddress:
Branford, Connecticut, US
Priority
Number:
201361811464 PDate:
12.4.2013Country:
US
Classification
Categories:
C07H 19/067, A61K 31/7072, A61P 31/14, C07B 59/00